Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper

被引：1
|
作者：
Qin, Hong [1 ]
You, Changqiao [1 ]
Yan, Feng [1 ]
Tan, Kefang [1 ]
Xu, Changgen [1 ]
Zhao, Rui [2 ]
Ekpo, Marlene Davis [2 ]
Tan, Songwen [2 ]
机构：
[1] NanHua Biomed CO Ltd, Res & Dev Dept, Changsha, Peoples R China
[2] Cent South Univ, Xiangya Sch Pharmaceut Sci, Changsha, Peoples R China
来源：
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词：
natural killer (NK) cells; immunosenescence; immunotherapy; cancer; chemotherapy; biotherapeutics; CAR-NK CELLS; CORD BLOOD; ADOPTIVE TRANSFER; CYTOKINE RELEASE; IN-VIVO; IMMUNOTHERAPY; ACTIVATION; EXPANSION; THERAPY; TRANSPLANTATION;
D O I：
10.3389/fonc.2022.1062765
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [1] The development of stroke therapeutics: Promising mechanisms and translational challenges
    Zaleska, Margaret M.
    Mercado, Mary Lynn T.
    Chavez, Juan
    Feuerstein, Giora Z.
    Pangalos, Menelas N.
    Wood, Andrew
    NEUROPHARMACOLOGY, 2009, 56 (02) : 329 - 341
  • [2] Overcoming the challenges of conducting translational research in cell therapy
    Viswanathan S.
    Keating A.
    Frontiers of Medicine, 2011, 5 (4) : 333 - 335
  • [3] Opinion - Anticipating change in drug development: the emerging era of translational medicine and therapeutics
    FitzGerald, GA
    NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (10) : 815 - 818
  • [4] Human natural killer cell development
    Freud, Aharon G.
    Caligiuri, Michael A.
    IMMUNOLOGICAL REVIEWS, 2006, 214 : 56 - 72
  • [5] Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors
    Nayyar, Gaurav
    Chu, Yaya
    Cairo, Mitchell S.
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [6] Addressing Natural Killer Cell Dysfunction and Plasticity in Cell-Based Cancer Therapeutics
    Coyle, Kassandra M.
    Hawke, Lindsey G.
    Ormiston, Mark L.
    CANCERS, 2023, 15 (06)
  • [7] A defining factor for natural killer cell development
    James P Di Santo
    Nature Immunology, 2009, 10 : 1051 - 1052
  • [8] Osteopontin is required for natural killer cell development
    Kim, Mi Sun
    Piao, Zheng-Hao
    Jeong, Mira
    Yoon, Suk Ran
    Chung, Jin Woong
    Choi, Inpyo
    JOURNAL OF IMMUNOLOGY, 2009, 182
  • [9] Human natural killer cell development and biology
    Farag, Sherif S.
    Caligiuri, Michael A.
    BLOOD REVIEWS, 2006, 20 (03) : 123 - 137
  • [10] A defining factor for natural killer cell development
    Di Santo, James P.
    NATURE IMMUNOLOGY, 2009, 10 (10) : 1051 - 1052
12345